1. Home
  2. VNCE vs GANX Comparison

VNCE vs GANX Comparison

Compare VNCE & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$5.10

Market Cap

82.0M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

88.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNCE
GANX
Founded
2002
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
88.6M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
VNCE
GANX
Price
$5.10
$1.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$5.17
$7.50
AVG Volume (30 Days)
96.4K
397.5K
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
132.45
31.46
EPS
N/A
N/A
Revenue
$300,007,000.00
$55,180.00
Revenue This Year
$5.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.23
N/A
52 Week Low
$1.95
$1.53
52 Week High
$8.20
$4.34

Technical Indicators

Market Signals
Indicator
VNCE
GANX
Relative Strength Index (RSI) 34.97 39.43
Support Level $3.99 $1.57
Resistance Level $5.90 $2.22
Average True Range (ATR) 0.50 0.09
MACD -0.12 -0.02
Stochastic Oscillator 1.90 2.78

Price Performance

Historical Comparison
VNCE
GANX

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: